All eight immune checkpoint genes were overexpressed in both GBM and LGG tumors (Figure 1), of which only HAVCR2 was significantly upregulated in both glioma types and PDCD1LG2 showed significant upregulation in GBM but not in LGG (p < 0.05). The gene discussed is HAVCR2; the disease is central nervous system cancer.